Viela Bio to Report Fourth Quarter and Full Year 2020 Operating and Financial Results on March 1, 2021

Rhea-AI Summary

Viela Bio (Nasdaq: VIE) announced it will release its fourth quarter and full year 2020 financial results on March 1, 2021, after market close. The company is currently involved in a merger with Horizon Therapeutics, announced on February 1, 2021. As a result, Viela will not hold a conference call for the earnings report. Relevant materials will be available on the company's Investor Relations page. Viela Bio focuses on developing treatments for autoimmune and severe inflammatory diseases.

GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases, today announced it will report its fourth quarter and full year 2020 operating and financial results after the U.S. financial markets close on Monday, March 1, 2021.

In light of the agreement and plan of merger by and among Viela Bio, Horizon Therapeutics, Inc., Teiripic Merger Sub, Inc., and Horizon Therapeutics plc, announced on February 1, 2021, Viela will not be hosting a conference call for its fourth quarter 2020 results. Earnings materials will be made available publicly on the Investor Relations page of Viela’s website at www.vielabio.com.

About Viela Bio

Viela Bio, headquartered in Gaithersburg, Maryland, is a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases. For more information, please visit www.vielabio.com.

Source: Viela Bio

Contacts:

Investors:
Solebury Trout
Chad Rubin
646-378-2947
crubin@soleburytrout.com

Media:
Solebury Trout
Amy Bonanno
914-450-0349
abonanno@soleburytrout.com

FAQ

When will Viela Bio report its Q4 2020 earnings?

Viela Bio will report its fourth quarter and full year 2020 earnings on March 1, 2021, after U.S. market close.

Is Viela Bio hosting a conference call for its Q4 2020 results?

No, Viela Bio will not host a conference call for its fourth quarter 2020 results.

What recent merger has Viela Bio announced?

Viela Bio announced a merger agreement with Horizon Therapeutics on February 1, 2021.

Where can I find the earnings materials for Viela Bio?

Earnings materials will be available on Viela Bio's Investor Relations page at their official website.